Brief: American Medical Association Is Reviewing Cardio Diagnostics Holdings, Inc’S Integrated Epigenetic-Genetic Cardiovascular Medicine Tests For Cpt Pla Codes
Cardio Diagnostics Holdings Inc CDIO.O :
* AMERICAN MEDICAL ASSOCIATION IS REVIEWING CARDIO
DIAGNOSTICS
HOLDINGS, INC’S INTEGRATED EPIGENETIC-GENETIC CARDIOVASCULAR
MEDICINE TESTS FOR CPT PLA CODES
* CARDIO DIAGNOSTICS HOLDINGS INC - IF APPROVED, CODES ARE
EXPECTED TO BE PUBLISHED BY AMA BY JANUARY 1, 2024, AND WILL BE
EFFECTIVE ON APRIL 1, 2024
Source text for Eikon: ID:nBw5jsFJFa
Further company coverage: CDIO.O
Recent news on Cardio Diagnostics Holdings
See all newsNASDAQ RESUMED AT 10:08 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:03 AM
Brief: Cardio Diagnostics And Southdale Ymca Announce New Heart Health Partnership
Brief: Cardio Diagnostics Holdings Inc - CMS Sets Final Payment Rate Of $854 For Cardiovascular Tests
Brief: Cardio Diagnostics Holdings Secures Japanese Patent For AI Cardiovascular Detection Technology